Sansure Biotech Inc. (SHSE: 688289)
Health Care · Health Care Equipment & Supplies · CN
CN¥15.78
-3.66% today · -29.3% 1Y
Sansure Biotech Inc. (SHSE: 688289) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.35B and employs 2,128 people.
Over the last twelve months the share price has lost 29.3%, trading between 13.40 and 22.94.
Tweenvest scores Sansure Biotech Inc. across four factors: quality 66/100, value 44/100, growth 37/100, dividend 74/100. Its strongest factor is dividend.
688289 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.35B
- Revenue (TTM)
- $232.46M
- P/E
- 60.05
- EPS
- 0.26
- Dividend yield
- 3.31%
- Beta (5Y)
- 0.49
- 52-week high
- CN¥22.94
- 52-week low
- CN¥13.40
- Avg volume (3M)
- —
- Shares outstanding
- 574.86M
- Employees
- 2,128
- Next earnings
- —
About Sansure Biotech Inc.
Sansure Biotech Inc., founded in Changsha, China, in 2008, is dedicated to the global development and commercialization of advanced diagnostic and research products. The company offers a diverse range of solutions, including upstream nucleic acid extraction kits, real-time PCR systems for both clinical and investigative purposes, and fluorescence detection platforms. Their extensive product portfolio encompasses diagnostic assays for critical conditions like the novel coronavirus, viral hepatitis, and AIDS. Furthermore, they provide blood screening and general extraction kits, tests for cancer-related biomarkers, and solutions for respiratory, sexually transmitted, digestive tract, prenatal, postnatal, and genetic diseases. Sansure Biotech also supplies essential laboratory instrumentation and various consumables, primarily serving hospitals and scientific laboratories worldwide.
- Founded
- 2008
- Listed since
- Aug 28, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €162.35 | -0.52% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.